As part of the monitoring process, a baseline weigh-in will be conducted, analyzing key benchmarks such as your BMI, body fat percentage, and muscle mass
Gastrointestinal effectsnausea, vomiting, and constipationare most frequent, typically mild to moderate during dose escalation
Mol Psychiatry 5 : 616632 Petty F, Kramer G, Wilson L
Weng Y, Yao J, Sparks S, Wang KY
Many plans require prior authorization, which means your clinician may need to document medical necessity and eligibility based on the FDA label
Surgery and Anesthesia Risk: The American Society of Anesthesiologists (ASA) recommends stopping weekly Semaglutide at least 1 week before elective surgery to reduce aspiration risk